Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL303697

LIGUSTRAZINE
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Cc1nc(C)c(C)nc1C

Basic Information

ChEMBL ID CHEMBL303697
Name LIGUSTRAZINE
Phase Preclinical
Structure Type MOL
InChI Key FINHMKGKINIASC-UHFFFAOYSA-N
13
Targets
27
Activities
2
Assay Types
1
PK Parameters
20
Publications
0
Known Names

Molecular Properties

136.2
MW (Da)
1.71
ALogP
2
HBA
0
HBD
25.8
PSA (Ų)
0.54
QED
0
Ro5 Violations
0
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

Natural Product First in Class Prodrug

Extended Properties

Molecular Formula C8H12N2
MW 136.20
Aromatic Rings 1
Heavy Atoms 10
NP-Likeness -0.45

Activity Summary

IC50 14 meas. best 5.31
EC50 13 meas. best 4.82

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
MDA-MB-231
CHEMBL400
IC50 5.31 5.0 4860.0 2
K562
CHEMBL385
IC50 5.29 5.29 5090.0 1
NCI-H1975
CHEMBL614348
IC50 5.25 5.25 5610.0 1
A549
CHEMBL392
IC50 5.19 4.8167 6420.0 3
HCT-116
CHEMBL394
IC50 5.09 5.09 8170.0 1
Unchecked
CHEMBL612545
IC50 5.02 5.02 9500.0 1
SK-HEP1
CHEMBL614912
IC50 5.01 5.01 9670.0 1
Unchecked
CHEMBL612545
EC50 4.82 4.82 15180.0 1
U-87 MG
CHEMBL614247
IC50 4.79 4.79 16150.0 1
SH-SY5Y
CHEMBL614910
EC50 4.75 4.75 17590.0 1
MCF7
CHEMBL387
IC50 4.53 4.53 29850.0 1
HepG2
CHEMBL395
IC50 4.42 4.42 38250.0 1
PC-12
CHEMBL612556
EC50 4.22 4.205 60000.0 2
NON-PROTEIN TARGET
CHEMBL3879801
EC50 4.08 4.08 83400.0 1

Pharmacokinetic Data

Parameter Value Units Species
T1/2 2.89 hr Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
MDA-MB-231 IC50 = 4860.0 nM 5.31 Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition... 37499289
K562 IC50 = 5090.0 nM 5.29 Antiproliferative activity against human K562 cells after 72 hrs in presence of ... 29424539
NCI-H1975 IC50 = 5610.0 nM 5.25 Antiproliferative activity against human NCI-H1975 cells assessed as inhibition ... 37499289
A549 IC50 = 6420.0 nM 5.19 Antiproliferative activity against human A549 cells assessed as inhibition of ce... 37499289
HCT-116 IC50 = 8170.0 nM 5.09 Antiproliferative activity against human HCT116 cells after 72 hrs in presence o... 29424539
Unchecked IC50 = 9500.0 nM 5.02 Antiproliferative activity against human LTEP-a2 cells assessed as inhibition of... 37499289
SK-HEP1 IC50 = 9670.0 nM 5.01 Antiproliferative activity against human SK-HEP1 cells assessed as inhibition of... 37499289
Unchecked EC50 = 15180.0 nM 4.82 Neuroprotective activity against H2O2-induced cell damage in human HBMEC2 cells ... 31541868
A549 IC50 = 15220.0 nM 4.82 Antiproliferative activity against human A549 cells after 72 hrs in presence of ... 29424539
U-87 MG IC50 = 16150.0 nM 4.79 Antiproliferative activity against human U87MG cells after 72 hrs in presence of... 29424539
SH-SY5Y EC50 = 17590.0 nM 4.75 Neuroprotective activity against H2O2-induced cell damage in human SH-SY5Y cells... 31541868
MDA-MB-231 IC50 = 20440.0 nM 4.69 Antiproliferation activity against human MDA-MB-231 cells assessed as reduction ... 34186178
MCF7 IC50 = 29850.0 nM 4.53 Antiproliferation activity against human MCF-7 cells assessed as reduction in ce... 34186178
A549 IC50 = 36460.0 nM 4.44 Antiproliferation activity against human A549 cells assessed as reduction in cel... 34186178
HepG2 IC50 = 38250.0 nM 4.42 Antiproliferation activity against human HepG2 cells assessed as reduction in ce... 34186178
PC-12 EC50 = 60000.0 nM 4.22 Neuroprotection against CoCl2-induced toxicity in rat PC12 cells 29432947
PC-12 EC50 = 64460.0 nM 4.19 Neuroprotection against CoCl2-induced toxicity in rat PC12 cells preincubated fo... 29432947
NON-PROTEIN TARGET EC50 = 83400.0 nM 4.08 Cytoprotective activity against H2O2-induced cytotoxicity in human EAhy926 cells... -

Literature References

PubMed DOI Target Context # Activities
26786697 10.1016/j.bmcl.2016.01.015 Rattus norvegicus 48
- 10.1039/C4MD00022F NON-PROTEIN TARGET 10
- 10.1039/C3MD20352B NON-PROTEIN TARGET 5
21993151 10.1016/j.ejmech.2011.09.030 ECV-304 5
- 10.6019/CHEMBL4495565 SARS-CoV-2 4
31444086 10.1016/j.bmcl.2019.08.012 Plasma 4
18790647 10.1016/j.bmc.2008.08.075 Rattus norvegicus 3
26891099 10.1021/acs.jmedchem.5b01203 Thioredoxin reductase 3
37499289 10.1016/j.ejmech.2023.115656 A549 2
29432947 10.1016/j.ejmech.2018.01.097 HUVEC 2
29432947 10.1016/j.ejmech.2018.01.097 PC-12 2
26891099 10.1021/acs.jmedchem.5b01203 A549/CDDP 2
22579617 10.1016/j.bmc.2012.04.016 NON-PROTEIN TARGET 2
26891099 10.1021/acs.jmedchem.5b01203 A549 2
- 10.6019/CHEMBL4651402 SARS-CoV-2 2
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
18790647 10.1016/j.bmc.2008.08.075 NON-PROTEIN TARGET 2
31444086 10.1016/j.bmcl.2019.08.012 No relevant target 2
37499289 10.1016/j.ejmech.2023.115656 Peroxiredoxin-1 2

Data from ChEMBL 36 via Core Engine